Abstract
Sexual recovery after prostate cancer (PCa) treatment is challenging. When expectations are that erectile response will quickly return to baseline, patients can often struggle when this does not happen. Further difficulty is experienced when patients encounter physical, psychological, and relational barriers to sexual adjustment. Drawing on the psychosocial research literature and on 15 years of clinical experience counseling PCa patients about sexual recovery, this paper outlines considerations for clinical practice. Suggestions include broadening the target for successful outcomes after Pca treatment beyond erectile function to include sexual distress and other sources of sexual concern. Clinicians are urged to consider individual differences such as the larger context of the patient, including their values and preferences, their treatment goals, and their relationship situation and status, in order to promote successful sexual adaptation. When introducing treatment approaches, the role of grief and loss should be assessed, and patients should be supported to foster realistic expectations about the recovery process. Suggestions for how to introduce various sexual strategies to patients are also offered, including ways to support patients in making and sustaining behavioral changes associated with sexual intervention. Clinicians are offered suggestions to promote patients’ sexual flexibility, prevent long periods of sexual inactivity, and help patients to identify various sexual motivators. Consideration of these psychological, relational, and social factors are all likely to help facilitate better sexual outcomes for PCa patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ussher JM, Perz J, Gilbert E, Wong WKT, Hobbs K. Renegotiating sex after cancer: resisting the coital imperative. Cancer Nurs. 2013;36:454–62.
Wittmann D, Carolan M, Given B, Skolarus TA, Crossley H, An L, et al. What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples’ sexual recovery after surgery for prostate cancer. J Sex Med. 2015;12:494–504.
Rabbani F, Schiff J, Piecuch M, Yunis LH, Eastham JA, Scardino PT, et al. Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years? J Sex Med. 2010;7:3984–90.
Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, et al. Are we improving erectile function recovery after radical prostatectomy? analysis of patients treated over the last decade. Eur Urol. 2019;75:221–8.
Wittmann D, Northouse L, Crossley H, Miller D, Dunn R, Nidetz J, et al. A pilot study of potential pre-operative barriers to couples sexual recovery after radical prostatectomy for prostate cancer. J Sex Marital Ther. 2015;41:155–68.
Santos-Iglesias P, Bergeron S, Brotto LA, Rosen NO, Walker LM. Preliminary validation of the Sexual Distress Scale-short form: applications to women, men, and prostate cancer survivors. J Sex Marital Ther. 2020;46:542–63.
Giesler RB, Miles BJ, Cowen ME, Kattan MW. Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings. Qual Life Res. 2000;9:645–65.
Reeve BB, Potosky AL, Willis GB. Should function and bother be measured and reported separately for prostate cancer quality-of-life domains? Urology 2006;68:599–603.
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905.
Kimura M, Banez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, et al. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfuntion. Andrology. 2013;1:256–61.
Nelson CJ, Deveci S, Stasi J, Scardino PT, Mulhall JP. Sexual bother following radical prostatectomy. J Sex Med. 2010;7:129–35.
Walker LM, Santos-Iglesias P. On the relationship between erectile function and sexual distress in men with prostate cancer. Arch Sex Behav. 2020;49:1575–88.
Santos-Iglesias P, Mohamed B, Walker LM. A systematic review of sexual distress measures. J Sex Med. 2018;15:625–44.
Derogatis LR, Rosen R, Leiblum S, Bennett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–30.
Santos-Iglesias P, Mohamed B, Danko A, Walker LM. Psychometric validation of the Female Sexual Distress Scale in male samples. Arch Sex Behav. 2018;47:1733–43.
Santos-Iglesias P, Walker LM. Psychometric validation of the Sexual Distress Scale in men with prostate cancer. J Sex Med. 2018;15:1010–20.
Walker LM, Wassersug RJ, Robinson JW. Psychosocial perspectives on sexual recovery after prostate cancer treatment. Nat Rev Urol. 2015;12:167–76.
Elterman DS, Petrella AR, Walker LM, Van Asseldonk B, Jamnicky L, Brock GB, et al. Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment. Can Urol Assoc J 2019;13:239–45.
McCarthy B, Fucito LM. Integrating medication, realistic expectations, and therapeutic interventions in the treatment of male sexual dysfunction. J Sex Marital Ther. 2005;31:319–28.
Wittmann D, Foley S, Balon R. A biopsychosocial approach to sexual recovery after prostate surgery: the role of grief and mourning. J Sex Marital Ther. 2011;37:130–44.
Fode M, Serefoglu EC, Albersen M, Sønksen J. Sexuality following radical prostatectomy: is restoration of erectile function enough? Sex Med Rev. 2017;5:110–9.
Frey A, Sønksen J, Jakobsen H, Fode M. Prevalence and predicting factors for commonly neglected sexual side effects to radical prostatectomies: results from a cross-sectional questionnaire-based study. J Sex Med. 2014;11:2318–26.
Amarasekera C, Wong V, Jackson K, Yura E, Patel M, Manjunath A, et al. A pilot study assessing aspects of sexual function predicted to be important after treatment for prostate cancer in gay men: an underserved domain highlighted. LGBT Heal. 2020;7:271–6.
Amarasekera C, Wong V, Yura E, Manjunath A, Schaeffer E, Kundu S. Prostate cancer in sexual minorities and the influence of HIV status. Nat Rev Urol Nat Publ Group. 2019;16:404–21.
Zaider T, Manne S, Nelson C, Mulhall J, Kissane D. Loss of masculine identity, marital affection, and sexual bother in men with localized prostate cancer. J Sex Med. 2012;9:2724–32.
Letts C, Tamlyn K, Byers ES. Exploring the impact of prostate cancer on men’s sexual well-being. J Psychosoc Oncol. 2010;28:490–510. https://doi.org/10.1080/07347332.2010.498457.
Ussher JM, Perz J, Kellett A, Chambers S, Latini D, Davis ID, et al. Health-related quality of life, psychological distress, and sexual changes following prostate cancer: a comparison of gay and bisexual men with heterosexual men. J Sex Med. 2016;13:425–34.
Mathew S, Rapsey CM, Wibowo E. Psychosocial barriers and enablers for prostate cancer patients in starting a relationship. J Sex Marital Ther. 2020;46:736–46.
Wassersug RJ, Lyons A, Duncan D, Dowsett GW, Pitts M. Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer. Urology 2013;82:565–71.
Gebert S. Are penile prostheses a viable option to recommend for gay men? Int J Urol Nurs. 2014;8:111–3.
Flynn KE, Lin L, Bruner DW, Cyranowski JM, Hahn EA, Jeffery DD, et al. Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of U.S. adults. J Sex Med. 2016;13:1642–50.
DeLamater J, Koepsel E. Relationships and sexual expression in later life: a biopsychosocial perspective. Sex Relatsh Ther. 2015;30:37–59.
Wittmann D, Carolan M, Given B, Skolarus TA, An L, Palapattu G, et al. Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer. Support Care Cancer. 2014;22:2509–15.
Grondhuis Palacios LA, den Ouden MEM, den Oudsten BL, Putter H, Pelger RCM, Elzevier HW. Treatment-related sexual side effects from the perspective of partners of men with prostate cancer. J Sex Marital Ther. 2019;45:440–51.
Tran SN, Wirth GJ, Mayor G, Rollini C, Bianchi-Demicheli F, Iselin CE. Prospective evaluation of early postoperative male and female sexual function after radical prostatectomy with erectile nerves preservation. Int J Impot Res. 2015;27:69–74.
Althof SE. When an erection alone is not enough: Biopsychosocial obstacles to lovemaking. Int J Impot Res 2002;14:S99–104.
Kukula KC, Jackowich RA, Wassersug RJ. Eroticization as a factor influencing erectile dysfunction treatment effectiveness. Int J Impot Res. 2014;26:1–6.
Carvalheira AA, Pereira NM, Maroco J, Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med. 2012;9:2361–9.
Nappi RE, Martini E, Cucinella L, Martella S, Tiranini L, Inzoli A, et al. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol. 2019;10:561.
Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S, Currie K, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol. 2005;174:2105–10.
Wibowo E, Wassersug RJ, Robinson JW, Santos-Iglesias P, Matthew A, McLeod DL, et al. An educational program to help patients manage androgen deprivation therapy side effects: feasibility, acceptability, and preliminary outcomes. Am J Mens Health. 2020;14:1557988319898991.
Lawrance K-A, Byers ES. Sexual satisfaction in long-term heterosexual relationships: the interpersonal exchange model of sexual satisfaction. Pers Relatsh. 1995;2:267–85.
Kelly MP, Barker M. Why is changing health-related behaviour so difficult? Public Health. 2016;136:109–16.
Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. In: Quality and Safety in Health Care. 2005. p. 26–33.
Miller WR, Rollnick S. Motivational interviewing: helping people change. New York, NY: Guilford Press; 2012.
Rose A, Rosewilliam S, Soundy A. Shared decision making within goal setting in rehabilitation settings: a systematic review. Patient Educ Couns. 2017;100:65–75.
Kleingeld A, van Mierlo H, Arends L. The effect of goal setting on group performance: a meta-analysis. J Appl Psychol. 2011;96:1289–304.
Matthews G Goal Research Summary. Paper presented at the 9th Annual International Conference of the Psychology Research Unit of Athens Institute for Education and Research (ATINER). In Athens, Greece; 2015. https://www.dominican.edu/sites/default/files/2020-02/gailmatthews-harvard-goals-researchsummary.pdf.
Moran C, Campbell TS. The case for patient-centred approaches in addressing statin nonadherence. Can J Cardiol. 2019;35:1605.e9.
Amrhein PC, Miller WR, Yahne CE, Palmer M, Fulcher L. Client commitment language during motivational interviewing predicts drug use outcomes. J Consulting Clin Psychol. 2003;71:862–78.
Lombardi DR, Button ML, Westra HA. Measuring motivation: change talk and counter-change talk in cognitive behavioral therapy for generalized anxiety. Cogn Behav Ther. 2014;43:12–21.
Schubert KA Sexual Scripts. In: Encyclopedia of Family Studies. American Cancer Society; 2016. p. 1–2. https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119085621.
Beck AM, Robinson JW, Carlson LE. Sexual values as the key to maintaining satisfying sex after prostate cancer treatment: the physical pleasure-relational intimacy model of sexual motivation. Arch Sex Behav. 2013;42:1637–47.
Kirby MG, White ID, Butcher J, Challacombe B, Coe J, Grover L, et al. Development of UK recommendations on treatment for post-surgical erectile dysfunction. Int J Clin Pr. 2014;68:590–608.
Linschoten M, Weiner L, Avery-Clark C. Sensate focus: a critical literature review. Sex Relatsh Ther. 2016;31:230–47.
Basson R. Human sex-response cycles. J Sex Marital Ther. 2001;27:33–43.
Masters WH, Johnson VE. Human sexual response. Boston, MA: Little, Brown & Co; 1966.
Meston CM, Buss DM. Why humans have sex. Arch Sex Behav. 2007;36:477–507.
Beck AM, Robinson JW. Sexual resiliency in couples. In: Skerrett K, Fergus K, editors. Couple resilience across the lifespan—emerging perspectives. New York: Springer; 2014.
Elliott S, Matthew A. Sexual recovery following prostate cancer: recommendations from 2 established canadian sexual rehabilitation clinics. Sex Med Rev. 2018;6:279–94.
Acknowledgements
The concepts introduced in this paper have been formulated over years of working with a fantastic team of collaborators. I would like to thank the following people for helping me formulate my approach to working with PCa patients in the area of sexual recovery. My direct research collaborators and/or mentors include: John Robinson, Andrew Matthew, Debbie MacLeod, Richard Wassersug, Jay Lee, Stacy Elliot, Rosemary Basson, Lori Brotto, Erik Wibowo, Andrea Beck and Pablo Santos-Iglesias. Some of the researchers and writers in the field who have influenced my work include: Anne Katz, Daniella Wittmann, Stanley Althof, Barry McCarthy, Christian Nelson, Jane Ussher, Sharon Bober, & Leslie Schover.
Funding
Salary support for LW is provided by the Arnie Charbonneau Cancer Institute and the Daniel Family Leadership Chair in PsychoOncology, at the University of Calgary.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
LW is a co-founder of the Androgen Deprivation Therapy Educational Program for prostate cancer patients. For more information see www.lifeonadt.com. The ADT program has received unrestricted educational grants from pharmaceutical companies that have been administered to the European Urology Association and to the Prostate Cancer Centre (Calgary, Alberta). Funding for the ADT Program (in Canada and in Europe) has been provided by the following companies: Astellas, AbbVie, Bayer.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Walker, L.M. Psychosocial contributors to patients’ and partners’ postprostate cancer sexual recovery: 10 evidence-based and practical considerations. Int J Impot Res 33, 464–472 (2021). https://doi.org/10.1038/s41443-020-00369-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41443-020-00369-5
This article is cited by
-
Sexual recovery interventions following prostate cancer treatment
Nature Reviews Urology (2022)
-
Future directions in improving sexual function for prostate cancer patients
International Journal of Impotence Research (2021)